ABBV - AbbVie ends Caribou agreement on CAR-T therapy development
2023-09-28 17:35:11 ET
More on AbbVie, Caribou Bioscience, etc.
- Caribou Biosciences: Antlers Up, Bullish Run In Phase 1 Trials
- AbbVie: Company Vs. Stock, A Gentle Facelift Would Be Nice (Technical Analysis)
- AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths
- AbbVie's Tepkinly wins EC approval as large B-cell lymphoma therapy
- AbbVie says late-stage study supports Botox for platysma prominence
For further details see:
AbbVie ends Caribou agreement on CAR-T therapy development